Ramez Kouzy, MD
@RKouzyMD
Followers
1K
Following
7K
Media
131
Statuses
1K
Radiation Oncology Resident, @MDAndersonNews working on AI-human augmentation and alignment | Via @UTSW_surgery, @TaniguchiMD lab, @AUB_Lebanon | Views=Mine
Houston, TX
Joined October 2010
If you are interested in reading more about the AI-powered pipeline we developed which can be used for other similar downstream healthcare related social media analysis you can find the methods preprint + code here:.
0
0
0
Takeaway: We need better data to to guide our patients RE GLP-1 and cancer risks. Our patients and survivors are already using these meds and we need to help them make informed decisions on risk/harm. If you are interested in reading more:
jamanetwork.com
This cross-sectional study analyzes social media posts to explore patient concerns and the extent of patient–clinician communication regarding cancer risks associated with glucagon-like peptide-1...
1
0
0
Key insights:.- Cancer survivors are turning to GLP-1s post-treatment to lose cancer/treatment related weight gain. - Thyroid + breast most mentioned. - Some believe GLP-1s might actually reduce risk and a few were able to feel lumps leading to a diagnosis post weight loss.
1
0
0
What are patients saying about GLP-1 meds and cancer risk?. We analyzed 400K+ Reddit posts using an AI-powered pipeline, revealing major communication gaps: overall cancer risk discussions were low but of those only 19% mentioned talking to a doctor. 🧵. @JAMANetworkOpen.
1
3
11
RT @docanoopmisra: New study explores cancer concerns around #GLP-1 meds on @Reddit:. #Thyroid & #breast cancer most mentioned. Only 19% t….
jamanetwork.com
This cross-sectional study analyzes social media posts to explore patient concerns and the extent of patient–clinician communication regarding cancer risks associated with glucagon-like peptide-1...
0
1
0
RT @JAMANetworkOpen: This cross-sectional study found that online discussions about GLP-1 medications often included cancer risk concerns,….
0
1
0
RT @ASTRO_org: Brachytherapy is Interventional Radiation Oncology. Today is Brachytherapy Awareness Day. ASTRO is pleased to join medical….
0
10
0
RT @JNCI_Now: Natural language processing across a large medical center ensures a rare diagnosis, inflammatory breast cancer, is not missed….
academic.oup.com
Abstract. Early identification and referral of inflammatory breast cancer remains challenging within large health-care systems, limiting access to speciali
0
3
0
RT @dbittermanmd: Are you driven to use AI to transform patient outcomes in oncology? My lab in the AI in Medicine Program (Mass General Br….
www.linkedin.com
🚀 Join Us at the Forefront of AI & Cancer Care Are you driven to use cutting-edge AI to transform patient outcomes in oncology? My lab within the AI in Medicine Program (Mass General Brigham,...
0
7
0
RT @EvanThomas84: Now we just insurance buy in. The cost savings of delayed progression to expensive 2nd and 3rd line therapies are well wo….
0
2
0
Check out our work with the stellar @lilyychenn and @sebajoed on why AI-powered health fact checking isn’t straightforward!.
Are we fact-checking medical claims the right way? 🩺🤔. Probably not. In our study, even experts struggled to verify Reddit health claims using end-to-end systems. We show why—and argue fact-checking should be a dialogue, with patients in the loop. 🧵1/
0
1
3
I’m very impressed by Director! It automated a pipeline that can search select medical journals for specific topics and give me a personalized newsletter. Excited to play more with this and see what is it capable of doing in healthcare. Kudos to the team!.
Developers automated the web. Now everyone can. Announcing Director and our $40M Series 🅱️
0
1
6
Happy to share our report on an NLP + targeted human approach deployed over 1.5 years across 8.6M clinical notes to detect and refer inflammatory breast cancer cases to a specialized IBC clinic @IBCradiation
academic.oup.com
Abstract. Early identification and referral of inflammatory breast cancer remains challenging within large health-care systems, limiting access to speciali
3
5
28
RT @neurobuckets: One thing I love about using an AI scribe: I can let patient conversations flow naturally, without forcing them into the….
0
3
0
RT @EricTopol: The first generative AI drug to get to a Phase 2 randomized clinical trial. The small molecule in pill form, rentosertib, sh….
0
100
0
RT @ebludmir: Terrific work by @AlexSherryMD and wonderful colleagues including CSO friends, w simultaneous pub in @JAMAOnc .
jamanetwork.com
This meta-epidemiological study analyzes phase 3 oncology randomized clinical trials to determine the proportions of trials that show improvement in overall survival, quality of life, and alternative...
0
9
0
RT @fumikochino: 🚨 Dr @lee_kamaria is presenting her #ASCO25 #bcsm research tomorrow! Don't miss it!. "Patient-reported communication & sat….
0
3
0
RT @dbittermanmd: Does your LRM reason in your language? Check out new preprint led by ✨ @Jirui_Qi & @shan23chen. Implications for safety/h….
0
1
0